Breast cancer biomarkers: proteomic discovery and translation to clinically relevant assays.
about
Mass spectrometry for the detection of potential psychiatric biomarkersHands-on workshops as an effective means of learning advanced technologies including genomics, proteomics and bioinformaticsStrategies for modern biomarker and drug development in oncology.Novel serum protein biomarker panel revealed by mass spectrometry and its prognostic value in breast cancer.Bayesian proteoform modeling improves protein quantification of global proteomic measurements.Tropomyosin-4 correlates with higher SBR grades and tubular differentiation in infiltrating ductal breast carcinomas: an immunohistochemical and proteomics-based study.Plasma Proteomic Profiling in Hereditary Breast Cancer Reveals a BRCA1-Specific Signature: Diagnostic and Functional Implications4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer.Type 1 diabetes cadaveric human pancreata exhibit a unique exocrine tissue proteomic profileDiagnostic and prognostic significance of serum apolipoprotein C-I in triple-negative breast cancer based on mass spectrometryHuman induced pluripotent stem cells from basic research to potential clinical applications in cancerApplication of proteomics in the study of rodent models of cancer.Proteomic analysis of tissue samples in translational breast cancer research.Contemporary proteomic strategies for clinical epigenetic research and potential impact for the clinic.Isobaric Labeling-Based LC-MS/MS Strategy for Comprehensive Profiling of Human Pancreatic Tissue Proteome.Affinity proteomic profiling of plasma for proteins associated to area-based mammographic breast density.
P2860
Q26852637-24180885-D5AD-45F1-98E9-859B5E396A82Q28387396-1615147B-2685-4C5E-A7F2-9BFD02238697Q30590270-6AA59E68-BA33-4E38-AFE0-DF6610167501Q33892389-B314E14A-ECC8-4D16-9F1E-78F5065226A2Q34635023-A3834929-9C15-40FB-A6E2-4A99870524BFQ34787142-B3A10E9B-99DD-42B5-B33C-1E9AF8F920B4Q35659498-3241EF2F-6E98-42CB-927E-D45F3CBA4D7BQ35749170-35EE0EB5-6389-41EF-B957-A38CED01B15DQ36970856-61AB1C79-7B3E-44A7-8428-DA8D5C273781Q37187745-2BB5A5A7-4DE5-4F44-81AA-D2F997168625Q37316328-1D934345-FB4C-4146-ADA7-0AF7651E56A3Q38194543-0319E2E7-1DEF-4A9A-AB1B-5E0A12189C31Q38212502-D44EF3EC-779A-4B59-9372-B65C0A9F63F3Q38365443-536615A1-2914-48B1-B05A-0E346AB802A5Q47684191-EA9312C4-41BD-4279-836D-10C0EDF9E47DQ49416704-D40F2961-DFB2-4DDD-A432-CAD026FAB2C9
P2860
Breast cancer biomarkers: proteomic discovery and translation to clinically relevant assays.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Breast cancer biomarkers: prot ...... to clinically relevant assays.
@en
type
label
Breast cancer biomarkers: prot ...... to clinically relevant assays.
@en
prefLabel
Breast cancer biomarkers: prot ...... to clinically relevant assays.
@en
P2860
P356
P1476
Breast cancer biomarkers: prot ...... to clinically relevant assays.
@en
P2093
Liping Chung
Robert C Baxter
P2860
P304
P356
10.1586/EPR.12.62
P577
2012-12-01T00:00:00Z